Navigation Links
The American Federation for Medical Research Says Daschle Must Cure Clinical Research Crisis if Change Is To Take Hold in U.S. Health Care System
Date:12/11/2008

BOSTON, Dec. 11 /PRNewswire-USNewswire/ -- The American Federation for Medical Research (AFMR) announces its full support of Former Senate Majority Leader Tom Daschle's appointment to the post of Health and Human Services secretary. Mr. Daschle will serve as President-elect Obama's top administration official to overhaul the nation's health care system.

As a result of its work since 1940, the AFMR believes firmly that improving clinical research in the U.S., which weakened significantly during the Bush administration, is a lynchpin to achieving sustainable change in the U.S. health care system. The AFMR pledges the full support of its human resources, medical expertise and scientific knowledge to Mr. Daschle and the Obama administration for the advancement of clinical research, including its leading U.S. physician members and Nobel laureates who have made significant contributions to modern medicine and patient care through clinical research.

"Medical science and the U.S. health care system cannot progress without clinical research," said Dr. Alan Buchman, president of the AFMR and a prominent physician in gastroenterology. "Yet our nation has neglected the advancement of clinical research -- that which involves patients directly -- which can prevent disease, lead to more effective disease treatments, medical breakthroughs for chronic diseases, and cut the astronomical costs and inefficiencies that plague our health care system. Mr. Daschle has the opportunity to fix this fundamental issue early on, which will have an enormous positive ripple effect on the rest of the health care system," said Buchman.

The U.S. clinical research crisis stems from two primary issues: 1) Federal budget cuts for the NIH, particularly in funds spent on clinical research and the education and training of future clinical investigators and physician-scientists, and 2) Lack of support for future physician-scientists, whos
'/>"/>

SOURCE American Federation for Medical Research
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
6. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
7. Novo Nordisk Appoints New Leader of North American Business
8. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
9. Primary biliary cirrhosis more severe in African-American and Hispanic patients
10. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
11. American Chemical Societys Weekly Presspac -- Sept. 5, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)... treatment equals a $41,000 pay raise, researchers...ws) -- Psychological therapy may be much more effe...or winning a lottery prize, suggests an English st...f people who provided information about their ment...ness from a $1,329 course of therapy was so signif...
(Date:11/29/2009)...he YogaForce A-Line Athletic Mat is great. It,s a...., author and physician best known for establishin...ne. Go to www.yogaforce.com and order the new M... , San Francisco, CA (PRWE...ays, the YogaForce newly patented, revolutionary A...
(Date:11/28/2009)...RNewswire/ -- Welcome to syngo® .plaza(... routine from Siemens Healthcare. As the first...CS) from Siemens where 2D, 3D, and 4D reading co...sed to change the way multimodality images are rea... the 95th Scientific Assembly and Annual Meeting o...
(Date:11/28/2009)... to consider change after 30-minute psychosocial i.... 27 (HealthDay News) -- A program that gets persi...op their dangerous behavior may lead to significan.... , The new study included 184 men and women wi... who were randomly assigned to one of two interven...
(Date:11/28/2009)...pirits, recognize signs of depression , ,...eniors, the holiday season can trigger melancholy ... health issues or worry about money problems, acco...help overcome the seasonal blues, the AGS Foundati...: , Get out and socialize or invite family and f...
Breaking Medicine News(10 mins):Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Seniors May Need Help Overcoming Holiday Blues 2
...ass., Jan. 15 No one who survives life-threatenin...rson who entered. In her new memoir, "It Gets Bett...orhouse.com ), Maria Machado Munroe draws together... prose she creates an inspirational recounting for...
...n. 15 Kim Alexis is a supermodel, athlete, mother... the Look," where women compete to be the world,s ...Multimedia News Release, go to: http://www.prnews...of energy for no apparent reason, she grew concern...
...ina, Jan. 15 /PRNewswire-Asia-FirstCall/ -- China ..."the Company") (Nasdaq: CSKI ), a,leading fully ...he-counter drugs in the People,s Republic of China...ucts in China since they address common everyday a...
..., Jan. 15 It,s no wonder that millions of America...an Podiatric Medical Association (APMA) estimates ... 75,000 miles on their feet. For many, the pain i...he most common foot problems are ,hammertoes:, a b...
...Jan. 15 Today marked the launch of the National B...ww.nabita.org ). , , NaBITA,s mission: The Nati...ITA) is committed to providing education, developm...vention and intervention. , , NaBITA is a state-...
...IS, Jan. 15 Eli Lilly and Company,(NYSE: LLY ) ...h the United,States Attorney for the Eastern Distr...mer Litigation of the Department of Justice regard...,Zyprexa(R) (olanzapine). , Lilly has been coo...
Other Medicine News:Health News:Cancer as a Crucible: The Story of a Teenage Immigrant Who Survived Cancer and Built a New Life for Herself 2Health News:Cancer as a Crucible: The Story of a Teenage Immigrant Who Survived Cancer and Built a New Life for Herself 3Health News:Video: Supermodel Kim Alexis Joins Forces with the American Association of Clinical Endocrinologists in a National PSA to Raise Awareness About Thyroid Problems 2Health News:China Sky One Medical, Inc. Provides Business Update 2Health News:China Sky One Medical, Inc. Provides Business Update 3Health News:New Smart Toe Implant Lets Foot Surgery Patients Go 'Wireless' 2Health News:New Smart Toe Implant Lets Foot Surgery Patients Go 'Wireless' 3Health News:New Smart Toe Implant Lets Foot Surgery Patients Go 'Wireless' 4Health News:Preventing the Next Virginia Tech -- The National Behavioral Intervention Team Association Launched Today 2Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 2Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 3Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 4Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 5Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 6Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 7
(Date:11/27/2009)...INGTON, Minn, Nov. 27 ACUO TECHNOL...e management software, data migration tools and se...tes Patent and Trademark Office has approved a pat... within a Computer Network." Acuo Technologies is ... intellectual property. In general, the granted pa...
(Date:11/26/2009)...JOHANNESBURG, South Africa, Nov. 26 /PRNewswire/ -...ny of the Year Award in the Generic Pharmaceutical...Limited. ,, (Logo: http://www.newscom.com/cgi-...f the Year Award, the following criteria were used...ey competitors: growth strategy and implementation...
(Date:11/25/2009)...WESTON, Fla., Nov. 25 ...SFX) ("the Company") is pleased to announce that t...n management office in Shanghai, China. ,, ASR ...ng an essential gateway for the development and pr...roducts for children and adults to be distributed ...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2Sucrets 28R 29 ICE and Twentieth Century Fox Home Entertainment Challenge Kids to Keep the Environment Healthy this Cold Season 5699 1Sucrets 28R 29 ICE and Twentieth Century Fox Home Entertainment Challenge Kids to Keep the Environment Healthy this Cold Season 5699 2Sucrets 28R 29 ICE and Twentieth Century Fox Home Entertainment Challenge Kids to Keep the Environment Healthy this Cold Season 5699 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 1New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 2New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 4New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 5New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 6New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 7New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 8New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 9New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 10Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences 5693 1Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences 5693 2
...r 11- and 12-year-olds from,meningitis, whooping c...ATLANTA, Aug 28 The Centers for Disease,Control a...tion and,Respiratory Diseases today announced that... the parents of pre-teens are now available to bro...ts, part of CDC,s Pre-Teen,Vaccine campaign, urge ...
...: ICLL) today,announced that its collaborator Merc...ial of V710, an investigational vaccine for the pr...ctions. This randomized double blind,placebo contr...genicity of,the vaccine candidate in patients with...ial start follows the initiation of a separate Pha...
Other Medicine Technology:Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 2Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 3
Silicone Sleeve (270 Style)
Meridional Implant (103 Style)
Double Tantalum Clip
Ryan Silicone Strip
Medicine Products: